Specialist cancer nurse-led telehealth symptom management and care coordination for Australians affected by pancreatic cancer: The PANConnect randomised controlled trial
- Conditions
- Pancreatic cancerCancer - PancreaticPublic Health - Other public health
- Registration Number
- ACTRN12624001034527
- Lead Sponsor
- Peter MacCallum Cancer Centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 146
Patients with pancreatic cancer, family members and support people (carers) of patients with pancreatic cancer, healthcare professionals providing care to patients with pancreatic cancer at trial sites and the study specialist nurses delivering the intervention will be invited to participate.
Patients with pancreatic cancer are eligible to participate if they:
1.Are aged 18 years or older;
2.Have a confirmed diagnosis of pancreatic adenocarcinoma at any stage, independent of resectability;
3.Have a life expectancy of at least three months, as indicated by their treating consultant;
4.Have a documented cancer treatment plan in place, known to the patient; and
5.Are receiving their initial care at a trial site.
Carers are eligible to participate if they:
1.Are aged 18 years or older;
2.Able to speak and read English.
Healthcare professionals are eligible if they are providing or have provided care to patients recruited to the trial.
Patients with pancreatic cancer will not be eligible if they do not have capacity to provide informed consent (e.g., suffering from dementia or delirium). In addition, participants who do not have access to a telephone (mobile or landline) will not be eligible to participate.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method